PANoptosis: A novel therapeutic target in kidney disease (Review)
International Journal of Molecular Medicine · 26.09.2025 · 56 (6) · 1-17
DOI: 10.3892/ijmm.2025.5648 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 26.09.2025. Verfasst von Lianyan Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610032, P.R. China. Hauptthemen laut MEDLINE: Kidney Diseases, Pyroptosis, Necroptosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The global prevalence of kidney diseases continues to rise annually, posing a serious public health challenge, and notably contributing to morbidity and mortality rates worldwide. In affected individuals, kidney function progressively declines, ultimately resulting in renal failure. Therefore, elucidating the pathophysiological mechanisms underlying kidney diseases and identifying novel therapeutic targets is of paramount importance. Among these, the regulation of cell death pathways has emerged as a pivotal factor in disease progression. PANoptosis, a recently characterized form of programmed cell death, is activated by diverse stimuli, and involves the integrated activation of pyroptosis, apoptosis and necroptosis, coordinated through the PANoptosome complex. Increasing evidence has suggested that PANoptosis serves an important role in the development of kidney diseases, and further investigation into its regulatory mechanisms may provide valuable insights into disease modulation. The present review summarizes current knowledge regarding the mechanisms of PANoptosis and its involvement in various kidney diseases, offering perspectives for future diagnostic and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610032, P.R. China.
- Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China.
- Department of Nephrology, The Chinese University of Hong Kong, Shenzhen Medical Centre, Shenzhen, Guangdong 518100, P.R. China.
Zitieren
APA
Jiang, L., Zhao, L., Liu, Y., Fu, Z., Wu, M., Mou, Z., & Li, M. (2025). PANoptosis: A novel therapeutic target in kidney disease (Review). International Journal of Molecular Medicine, 56(6), 1-17. https://doi.org/10.3892/ijmm.2025.5648
Vancouver
Jiang L, Zhao L, Liu Y, Fu Z, Wu M, Mou Z, et al. PANoptosis: A novel therapeutic target in kidney disease (Review). International Journal of Molecular Medicine. 2025;56(6):1-17. doi:10.3892/ijmm.2025.5648
BibTeX
@article{Jiang2025,
author = {Jiang, Lianyan and Zhao, Liangbin and Liu, Yu and Fu, Zhongmei and Wu, Mengzhu and Mou, Zengyi and Li, Mingquan},
title = {PANoptosis: A novel therapeutic target in kidney disease (Review)},
journal = {International Journal of Molecular Medicine},
year = {2025},
volume = {56},
number = {6},
pages = {1--17},
doi = {10.3892/ijmm.2025.5648}
}
EUVIMED